125 results on '"Harboe E"'
Search Results
2. Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome
3. Loss of cerebral white matter in primary Sjögrenʼs syndrome: a controlled volumetric magnetic resonance imaging study
4. High headache-related disability in patients with systemic lupus erythematosus and primary Sjögrenʼs syndrome
5. Headache in primary Sjφgrenʼs syndrome: a population-based retrospective cohort study
6. ORIGINAL ARTICLE: Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögrenʼs syndrome
7. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study
8. Cerebral white matter hyperintensities are not increased in patients with primary Sjögrenʼs syndrome
9. Fatigue is associated with cerebral white matter hyperintensities in patients with systemic lupus erythematosus
10. Neuropsychiatric symptoms in patients with multiple sclerosis
11. THE SPECTRUM OF PERIPHERAL NEUROPATHY IN PRIMARY SJÖGRENʼS SYNDROME
12. The blood–brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren’s syndrome
13. OP0217 A permeable blood-brain barrier is not required for neuropsychatric manifestations in sle and pss
14. Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome
15. Headache-related disability in patients with systemic lupus erythematosus and primary Sjøgren'/INS;s syndrome
16. Headache in primary S jøgren's syndrome: a population‐based retrospective cohort study
17. The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties
18. Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome
19. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjogren syndrome: a comparative population-based study
20. In Vitro Stability of Insulin Aspart in Simulated Continuous Subcutaneous Insulin Infusion Using a MiniMed® 508 Insulin Pump
21. Verdünnung von NovoRapid® (Insulinaspart 100 E/ml) mit Verdünnungsmedium für Isophan-Insulin (NPH) zur Insulinpumpentherapie in niedriger Dosierung beeinträchtigt nicht die in-vitro Stabilität
22. Das skandinavische Erdbeben am 23 Oktober 1904. — Gerlands Beiträge zur Geophysik.
23. Den internationale, sejsmologiske Association.
24. Den første, internationale Jordskjælvskonferents.
25. En sejsmologisk Oversigt.
26. Jordklodens Undersøgelse med Sejsmograf.
27. Jordrystelserne i Danmark ved det skandinaviske Jordskælv den 23 Oktober 1904
28. Meddelelser om Jordskælv og Yulkanudbrud
29. Correction to: Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.
30. Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.
31. Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome.
32. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.
33. Fatigue in Newly Diagnosed Inflammatory Bowel Disease.
34. Reply: To PMID 25156222.
35. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.
36. Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome.
37. A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study.
38. Memory dysfunction in primary Sjögren's syndrome is associated with anti-NR2 antibodies.
39. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome.
40. Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: a population-based study.
41. [Risk of infection through use of selective immunomodulating drugs for rheumatoid arthritis].
42. Oxidative stress, as measured by protein oxidation, is increased in primary Sjøgren's syndrome.
43. Interleukin-1 inhibition and fatigue in primary Sjögren's syndrome--a double blind, randomised clinical trial.
44. Migraine is frequent in patients with systemic lupus erythematosus: a case-control study.
45. Fatigue in primary Sjögren's syndrome--a link to sickness behaviour in animals?
46. Peripheral neuropathy in primary sjogren syndrome: a population-based study.
47. Intraepidermal nerve fiber densities in chronic inflammatory autoimmune diseases.
48. [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases].
49. [Transmission of methicillin resistant Staphylococcus aureus to primary health care workers in a home environment].
50. Macromolecular prodrugs. XV. Colon-targeted delivery--bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.